1. What is Strattera?
Strattera is a norepinephine reuptake inhibitor, a new class of treatment that works differently from the other ADHD medications available. What is Strattera?
2. How does Strattera work?
Strattera works by selectively blocking the reuptake of norepinephrine, a chemical messenger, or neurotransmitter, by certain nerve cells in the brain. This action increases the availability of norepinephrine, which is thought to be essential in regulating impulse control, organization and attention. The precise mechanism by which Strattera works on ADHD is not known.
3. How do I take Strattera?
• Take Strattera exactly as directed by your doctor. Strattera offers flexible dosing, once or twice daily. Discuss a convenient schedule for taking Strattera with your doctor.
• Strattera may be taken with or without food.
• If you miss a dose, take it as soon as possible, but do not take more than your total daily dose in any 24-hour period.
• If possible, take Strattera at the same time every day to keep on schedule.
• Strattera capsules should never be broken and sprinkled on food. They must be taken whole.
4. How effective is Strattera in controlling ADHD symptoms?
In each of six clinical trials, Strattera was statistically superior to placebo in reducing the symptoms of ADHD in children, adolescents and adults. The positive effects of Strattera were seen for overall ADHD symptoms including hyperactive/impulsive symptoms and inattentive symptoms.
5. What data are being used to support the approval of Strattera?
In six placebo-controlled studies, two in children, two in children and adolescents, and two in adults, Strattera significantly reduced core symptoms of ADHD, and was well tolerated. In all studies, participants met Diagnostic and Statistical Manual, 4th Edition (DSM-IV), criteria for ADHD.
Eli Lilly and Company is continuing to study Strattera in short-term and long-term trials. As of October 2002, more than 4,000 child and adolescents have taken Strattera in clinical trials for ADHD.
Now, ordinarily I'd not even bother mentioning novel medications here on the Bluelight forums, because we're mostly interested in the discussion of recreational drugs and harm minimisation related to them. However, IMHO this development could spell the end to the epidemic of stimulant abuse that is currently associated with over-prescribing ADHD medications.
Wherever will kids be able to get extra pocket money now, if they can't sell ther ADHD tablets?
BigTrancer